120359-56-0

Basic information

• Product Name: Benzene, 1,3-dibroMo-5-ethenyl-
• Synonyms: Benzene, 1,3-dibroMo-5-ethenyl-;3,5-DibroMostyrene
• CAS NO: 120359-56-0
• Molecular Formula: C₈H₆Br₂
• Molecular Weight: 261.94124
• Product Categories: Aromatics, Metabolites & Impurities
• Mol File: 120359-56-0.mol

Chemical Properties

• Boiling Point: 271.1±33.0 °C(Predicted)
• Appearance: /
• Density: 1.772±0.06 g/cm3(Predicted)
• Storage Temp.: Amber Vial, Refrigerator
• Solubility: Dichloromethane
• CAS DataBase Reference: Benzene, 1,3-dibroMo-5-ethenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1,3-dibroMo-5-ethenyl-(120359-56-0)
• EPA Substance Registry System: Benzene, 1,3-dibroMo-5-ethenyl-(120359-56-0)

Safety Data

• Hazardous Substances Data: 120359-56-0(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis Industry:
Benzene, 1,3-dibromo-5-ethenylis used as a key intermediate in the preparation of bisphosphane ligands and phenanthroline-based functionalized macrocycles and catenanes. Its unique structure allows for the formation of complex organic compounds with potential applications in various fields.
Used in Pharmaceutical Industry:
Due to its chemical properties, Benzene, 1,3-dibromo-5-ethenylcan be used as a building block for the synthesis of pharmaceutical compounds. Its reactivity and structural features make it a valuable component in the development of new drugs and therapeutic agents.
Used in Material Science:
Benzene, 1,3-dibromo-5-ethenylcan be utilized in the development of advanced materials, such as polymers and composites, due to its ability to undergo various chemical reactions. Its presence in these materials can impart specific properties, such as improved stability, reactivity, or selectivity, making them suitable for various applications.

Upstream product

• 56990-02-4 3,5-dibromobenzaldehyde 
• 2065-66-9 methyl-triphenylphosphonium iodide 
• 626-39-1 1,3,5-trisbromobenzene 
• 1779-49-3 Methyltriphenylphosphonium bromide 

Downstream Products

• 59785-43-2 3,5-dibromo-1-ethylbenzene 
• 1064652-66-9 3,5-diazidostyrene 
• 1268519-04-5 (1R,2R)-1,2-bis(3,5-dibromophenyl)ethane-1,2-diol 
• 1268519-05-6 (4R,5R)-4,5-bis(3',5'-dibromophenyl)-(1,3,2)-dioxathiolane-2,2-dioxide 
• 1268519-07-8 (2R,3R)-1-(ethoxycarbonyl)-2,3-bis(3',5'-dibromophenyl)cyclopropane-1-carboxylic acid 
• 1268519-08-9 (2R,3R)-2,3-bis(3',5'-dibromophenyl)cyclopropane-1,1-dimethanol 
• 1268519-09-0 (2R,3R)-2,3-bis(3',5'-diphenylphenyl)cyclopropane-1,1-dimethanol 
• 1268519-10-3 (2R,3R)-1,1-bis(chloromethyl)-2,3-bis(3',5'-diphenylphenyl)cyclopropane 
• 1268519-03-4 (2R,3R)-1,1-bis[(diphenylphosphanyl)methyl]-2,3-bis(3',5'-diphenylphenyl)cyclopropane 

Relevant articles and documents

Introduction of useful peripheral functional groups on [2]catenanes by combining Cu(i) template synthesis with click chemistry

Two protocols based on Cu(i) template synthesis and click reactions for the synthesis of functionalized [2]catenanes are described. A straightforward procedure, involving high dilution conditions at high temperatures (70 °C), affords [2]catenanes bearing two identical peripheral groups in high yields. For the preparation of non-symmetrically functionalized [2]catenanes, a second milder and simpler protocol was developed, generalizing and extending the method. The introduction of peripheral functional groups into the catenane structure opens up possibilities of using [2]catenanes as building blocks for preparation of even more complex structures.

A novel C2-symmetric bisphosphane ligand with a chiral cyclopropane backbone: Synthesis and application in the Rh(I)-catalyzed asymmetric 1,4-addition of arylboronic acids

The synthesis of a novel C2-symmetric bisphosphane ligand was accomplished starting from trans-(2R,3R)-bis(3′,5′-diphenylphenyl) cyclopropane-1,1-dimethanol as a key intermediate. This ligand was tested in the asymmetric rhodium(I)-catalyzed 1,

PHENOXYETHER DERIVATIVES AS PPAR MODULATORS

The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR), such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

Synthesis and characterization of stilbene derivatives for possible incorporation as smart additives in polymers used as packaging films

Several series of stilbene derivatives for possible use as smart additives in polymers used as packaging films have been prepared and characterized. Differential scanning calorimetry was performed on some of the stilbenes in order to determine any liquid crystal properties. Those compounds which had multiple phase transitions were also shown to have two liquid crystalline phases according to optical microscopy.